Rosy Future for Pharma

The future of pharmaceuticals may look worrying on the surface, but for many companies, such as GlaxoSmithKline, the opposite is in fact true, reports the Independent.

Whilst it seems that new drugs are becoming harder to develop as they often cannot effectively compete with existing drugs, most major pharmaceutical companies are more than equipped to continue successfully in the future. GSK, for example, has many promising drugs in the development stage at the moment, which the company believes will be granted regulatory approval in the next two years.

AstraZeneca, Shire and Hikma are three other companies who are facing the same problems and coming up with the same solutions. Shire in particular are doing well. The company has tripled profits in four years by buying and developing early stage drugs, with profits put back into the company to further develop their drugs. It seems with companies such as these, pharmaceutical development’s future is not so worrying as it has been portrayed.

Looking for a job in the pharmaceutical sector? Start by clicking here

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , ,

Cinven Buy Out Mercury Pharma

Private equity firm Cinven have agreed a deal to purchase Mercury Pharma for £465 million reports pharmabiz.com.

Cinven saw the opportunity to expand into a new field, with Mercury specialising in niche pharmaceuticals, with customers including many hospitals and pharmacies across the UK, as well as a large international market. This niche brand of pharmaceuticals is often protected from patent issues and so was another attractive prospect for Cinven in this deal.

Cinven partner, Supraj Rajagopalan believes this deal “is a fantastic platform for further consolidation in both the UK and internationally” before adding that the investment “demonstrates [Cinven’s] focus on acquiring European based companies with significant international growth prospects.”

John Beighton, CEO of Mercury Pharma, is “delighted to be partnering Cinven who … will provide invaluable expertise and investment.”

Are you looking for a new role in the pharmaceutical industry? Click here to search pharma industry jobs

Posted in Industry News, NewsTagged in , , , , , , , , , ,

Olympic anti doping lab to become research facility

The Telegraph has reported that the Olympics anti-doping laboratory  is to be developed after the Games into what officials say will be a world-class research facility that could help revolutionise healthcare.

The lab was provided and equipped by GlaxoSmithKline to carry out more than 6,000 drug tests during the London Olympic and Paralympic Games.

After the games, the London 2012 drug testing laboratories in Harlow, Essex, will become the world’s first “Phenome Centre”, where experts will explore how different people respond to particular diseases and treatments, David Cameron will say.

The £10 million project is aimed at discovering the biological reasons why some people are more vulnerable to particular diseases than others, and why some drugs are only effective in certain patients.  It is hoped that it will help find treatments for conditions like dementia and obesity.

 

Click here to see our latest clinical jobs

Follow us on Twitter @CKClinical to receive more industry news and CK jobs of the week updates

 

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , ,

Novartis Afinitor cancer treatment gets EU approval

As reported by Pharma times, Novartis’s Afinitor has now been approved in Europe as a treatment for advanced breast cancer.

The European Commission has approved Afinitor (everolimus) for use in combination with Pfizer’s Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer

Herve Hoppenot, Novartis Oncology president, said the approval of Afinitor is “an important milestone marking the first major advance for women in the European Union with hormone receptor-positive advanced breast cancer since the introduction of aromatase inhibitors more than 15 years ago!”

This could mean that by boosting the effectiveness of endocrine therapy, Afinitor significantly extends the time women with hormone receptor-positive advanced breast cancer live without tumour progression.

Click here to see our latest clinical roles in the UK and Europe

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , ,

Free flu vaccinations for all children in the UK using AZ’s Fluenz

The BBC has reported that the UK government have announced that children between the ages of two to 17-year-olds in the UK are to be offered annual flu vaccinations free of charge.

This will be the first initiative of its kind in the world and the Joint Committee on Vaccination and Immunisation (JCVI) believes even with moderate vaccination uptake among children of around 30% there will be 11,000 fewer hospitalisations and 2,000 fewer deaths each year. The children will be immunised using a nasal spray rather than an injection, starting in 2014 at the earliest.

The news is particularly good for AstraZeneca, as the JCVI has advised that its live attenuated intranasal influenza vaccine Fluenz should be the vaccine of choice for extending the programme, “given the evidence of effectiveness, protection against drifted strains and safety, and in the absence of any equivalently effective alternative authorised vaccine”.

 

Are you looking for a new job in the clinical industry?

 Click here to see our latest clinical jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , ,

Our Latest Pharmaceutical Jobs – 23.7.2012

Here is a list of the latest pharmaceutical jobs which CK Clinical is recruiting for in the UK and Europe. Please click on the links below to find out more and apply.

 

Regulatory Affairs Jobs

 

Clinical Jobs - CK ClinicalStatistics Jobs

Medical Information Jobs

Clinical Jobs - CK Clinical

Drug Safety Jobs

Pharmacovigilance Jobs

 Clinical Jobs - CK Clinical

Clinical Jobs

Posted in Featured Jobs, NewsTagged in , , , , , , , , , , , , , , ,

Biometrics jobs in Europe

Here are a few a of our latest Biometrics jobs in Europe:

 

Biostatistician – Belgium

Mylene Paumier is recruiting for a Biostatistician to join an international contract research organization at their site based in Belgium on a contract basis.

 

Medical Information Manager – Germany

Mylene Paumier is recruiting for a Medical Information Manager to join a global pharmaceutical company at their site based in Germany on a permanent basis.

 

Senior Biometrician – Switzerland

Mylene Paumier is recruiting for a Senior Biometrician to join a global pharmaceutical company at their site based in Switzerland on a permanent basis

 

Senior Programmer – Switzerland

Mylene Paumier is recruiting for a Senior Programmer to join a global pharmaceutical company at their site based in Switzerland on a permanent basis

Mylene Paumier - Biometrics Recruiter at CK Clinical

How to apply:

For more information or to apply for any of these roles please contact Mylene Paumier on 01438 743 047 or email mpaumier@ckclinical.co.uk

 

Click here to see our other jobs in Europe

Posted in Featured Jobs, NewsTagged in , , , , , , , , , , , , ,

Head of Experimental Medicine – London

Jim Gleeson at CK Clinical is recruiting for a permanent Head of Experimental Medicine to manage expanding Phase I operations at a world renowned London hospital.

Responsibilities:

As a Head of Experimental Medicine you will develop and grow a clinical research facility delivering highest quality First in Man studies and attract strategic partnerships with leading pharmaceutical, diagnostic and other companies within the healthcare arena. You will also have the following responsibilities:

  • Managing the set up of early phase trials, supporting the development of in house capabilities and the management of external partnerships
  • Ensuring that trials run on time and on budget as well as in compliance with all protocol and governance requirements
  • Line and budgetary management
  • Oversight of the Quality Management System
  • Ensuring the delivery of trial performance metrics, operational analysis reporting, patient recruitment and study scheduling for facility and satellite sites
  • Maintaining preparedness for internal and external audit and leading sites through such audits
  • Assessment of personnel, financial and material requirements for studies and co-ordination of necessary procurement
  • Act as an ambassador for the facility to ensure development of high quality trials and attraction of commercial studies to the organisation

Qualifications and skills:

The successful candidate for this Head of Experimental Medicine role will have the following qualifications and skills:

  • A relevant BSc, MSc or nursing qualification
  • Extensive experience of managing early phase clinical trials
  • Thorough knowledge of the regulatory frameworks governing early phase experimental trials
  • Experience of hosting audit and regulatory inspections
  • Line management experience
  • Quality Management Systems experienceJim Gleeson - Senior Consultant at CK Clinical

How to apply:

Apply online:

For more information or to apply for this Head of Experimental Medicine position please contact Jim Gleeson at jgleeson@ckclinical.co.uk or on 01438 842973. Please quote reference CL24677 in all correspondence.

 

Click here to see our latest clinical roles

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , ,

Our Latest Pharmaceutical Jobs – 09.07.2012

Looking for a job in the Pharmaceutical Industry? Please click on the links below to find out about our latest pharmaceutical jobs new in this week:

Drug Safety:

Medical Science Liaison

Pharmacovigilance Associate

Lead QPPV Scientific Advisor in London

Biometrics:

Biostatistician

Contract Statistical Programmer

Senior Biostatistician in Germany

Senior Programmer

Clinical:

Head of Experimental Medicine, London

Senior Clinical Manager in Switzerland

Medical Advisor

Medical Director

Regulatory affairs:

Associate Director Regulatory Affairs

Regulatory Executive – Worldwide Safety

Regulatory Manager, UK & Ireland

Senior Regulatory Affairs Manager/AD

Register your CV with CK Clinical

Not quite what you’re looking for? Click here to register your CV with CK Clinical today.

Once registered, one of our specialist Pharmaceutical Recruitment Consultants will be in contact to discuss your requirements and any relevant pharmaceutical jobs we are recruiting for at the moment. Good luck with your job hunt!

Posted in Featured Jobs, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

Senior Quality Assurance Auditor – London

Jim Gleeson at CK Clinical is recruiting for a Senior Quality Assurance Auditor to join a leading healthcare charity at their site in London

Responsibilities:

As a Senior Quality Assurance Auditor you will be supporting a busy drug development team within a leading healthcare charity where you will plan, execute and report on Phase I and II clinical trials. These audits will be both internal and external and include Investigator Sites, laboratories, documentation, TMFs and databases. Activities will include assisting in staff training, representing the organisation at conferences and the review and update of SOPS.

Qualifications:

To be considered for this Senior Quality Assurance Auditor role you must have the following qualifications and skills:

  • BSc or Nursing qualification
  • QA auditing experience gained within clinical trials
  • An excellent understanding of ICH GCP
  • A good knowledge of the EU clinical trials regulatory documents that affect UK clinical trials
  • Excellent interpersonal skills and able to work in a highly collaborative fashionJim Gleeson -  Senior Recruiter at CK Clinical

How to apply:

Apply online:

For more information please contact Jim Gleeson on 01438 743 047 or email jgleeson@ckclinical.co.uk. Please quote reference CL24650 in all correspondence

Click here to see our latest clinical jobs

 

Posted in Featured Jobs, NewsTagged in , , , , , , , , , , ,